Literature DB >> 17385686

Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

La-or Chailurkit1, Wallaya Jongjaroenprasert, Suwannee Chanprasertyothin, Boonsong Ongphiphadhanakul.   

Abstract

Impaired pancreatic beta cell function and insulin sensitivity are fundamental factors in the pathogenesis of type 2 diabetes; however, the predominant defect appears differ among ethnic groups. We conducted a cross-sectional study to evaluate the contribution of impaired beta cell function and insulin sensitivity at different stages of the deterioration of glucose tolerance in Thais. The study involved 420 urban Thais of both sexes, 43-84 years old. A 75-g oral glucose tolerance test was performed on all of the subjects. Indices of insulin resistance and beta cell function were calculated with the use of a homeostasis model assessment. The subjects were classified as having normal glucose tolerance (NGT), isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), combined IFG and IGT, or type 2 diabetes mellitus according to the American Diabetes Association (ADA) criteria. There were no differences between groups with regard to gender and age. The percentage of obesity was significantly greatest in the diabetic group. Fasting serum insulin and C-peptide levels progressively increased from the NGT to the diabetic subjects. Serum C-peptide was more strongly associated with newly diagnosed diabetes than insulin, and was an independent factor associated with newly diagnosed diabetic subjects. The insulin resistance index progressively increased when the glucose tolerance stage changed from NGT through diabetic subjects. Beta cell function did not change significantly in any other group compared to the NGT group. An increase in fasting serum C-peptide may be a risk factor for type 2 diabetes. Obesity and insulin resistance are the predominant features in the deterioration of glucose tolerance in Thais. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385686      PMCID: PMC6649081          DOI: 10.1002/jcla.20138

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  33 in total

1.  Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.

Authors:  C N Jones; D Pei; P Staris; K S Polonsky; Y D Chen; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

2.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

Authors:  E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

3.  Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.

Authors:  K C Chiu; P Cohan; N P Lee; L M Chuang
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

Review 4.  Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.

Authors:  D Porte
Journal:  Diabetes Metab Res Rev       Date:  2001 May-Jun       Impact factor: 4.876

5.  Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.

Authors:  H Yeni-Komshian; M Carantoni; F Abbasi; G M Reaven
Journal:  Diabetes Care       Date:  2000-02       Impact factor: 19.112

6.  The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia.

Authors:  Wichai Aekplakorn; Ronald P Stolk; Bruce Neal; Paibul Suriyawongpaisal; Virasakdi Chongsuvivatwong; Sayan Cheepudomwit; Mark Woodward
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

Review 7.  C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.

Authors:  K S Polonsky; A H Rubenstein
Journal:  Diabetes       Date:  1984-05       Impact factor: 9.461

8.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

9.  Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance.

Authors:  M J Davies; G Rayman; A Grenfell; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1994-06       Impact factor: 4.359

10.  Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.

Authors:  S M Haffner; R D'Agostino; M F Saad; M Rewers; L Mykkänen; J Selby; G Howard; P J Savage; R F Hamman; L E Wagenknecht
Journal:  Diabetes       Date:  1996-06       Impact factor: 9.461

View more
  5 in total

1.  Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old.

Authors:  Hau D Do; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Res Clin Pract       Date:  2010-05-13       Impact factor: 5.602

2.  Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals.

Authors:  Jin-Young Min; Kyoung-Bok Min
Journal:  Eur J Epidemiol       Date:  2013-08-06       Impact factor: 8.082

3.  C-peptide levels and the risk of diabetes and pre-diabetes among Chinese women with gestational diabetes.

Authors:  Ping Yin; Ping Shao; Huikun Liu; Weiqin Li; Leishen Wang; Jing Wang; Shuang Zhang; Junhong Leng; Nan Li; Huiguang Tian; Xilin Yang; Zhijie Yu; Gang Hu
Journal:  J Diabetes Complications       Date:  2017-08-17       Impact factor: 2.852

4.  Late onset of type 2 diabetes is associated with mitochondrial tRNATrp A5514G and tRNASer(AGY) C12237T mutations.

Authors:  Liuchun Yang; Qinxian Guo; Jianhang Leng; Keyi Wang; Yu Ding
Journal:  J Clin Lab Anal       Date:  2021-11-22       Impact factor: 2.352

5.  C-peptide is a predictor of telomere shortening: A five-year longitudinal study.

Authors:  Racha Ghoussaini; Hani Tamim; Martine Elbejjani; Maha Makki; Lara Nasreddine; Hussain Ismaeel; Mona P Nasrallah; Nathalie K Zgheib
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.